Industry News

Exosome Diagnostics, Inc. announces the publication of positive data from its initial clinical study of ExoIntelliScore™ Prostate

exosome rna

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced the publication of positive data from its initial clinical study of ExoIntelliScore™ Prostate (previously referred to as EXO 106). The first-catch urine-based, three-gene signature liquid biopsy ...

Read More »

Exosome Diagnostics Launches CLIA-Certified Laboratory

exosome rna

Company centralizing U.S. operations ahead of cancer liquid biopsy test launches in 2015 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced that it has opened a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in Cambridge, ...

Read More »

Foundation Medicine Initiates Multi-Center Clinical Study Evaluating Its Circulating Tumor DNA (ctDNA) Assay in Multiple Tumor Types

exosome rna

Study Aims to Validate Assay and Identify Appropriate Clinical Subpopulations for Commercial Use CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced the initiation of a large-scale, multi-center prospective clinical study to validate its circulating tumor DNA (ctDNA) assay for multiple, ...

Read More »